AstraZeneca’s quest for Covid-19 vaccine gets $1bn boost from US
Thursday, 21 May 2020 () London — UK pharmaceuticals group AstraZeneca says it has secured more than $1bn from the US to help fund production of its coronavirus vaccine. AstraZeneca is partnering with the University of Oxford to develop and distribute a vaccine being trialled in the UK. It comes amid concerns that the US — which has the world's highest official death rate from Covid-19 — could have a vaccine before other countries thanks to its large-scale funding of multinational pharmaceutical companies. France has criticised Paris-based drugs giant Sanofi for suggesting the US would receive its vaccine first, as world...
AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial. Ciara Lee reports
Scientists around the world are working to get a COVID-19 vaccine approved, but only about half of Americans say they would actually get it. According to a poll from the Associated Press, 70% of people..
Credit: KTNV Channel 13 Las Vegas Duration: 00:32Published